Research spotlight: Innovative strategies guide head and neck cancer treatment

April is Head and Neck Cancer Awareness Month.

The observance is intended to raise awareness about these types of malignancies and the need for more effective therapies.

In conjunction with this campaign, Healio presents the following updates in head and neck cancer research and treatment.

Mid-treatment imaging helped guide de-escalation of radiation for certain patients with oropharynx cancer. Read more.
A follow-up strategy without radioiodine appeared noninferior to an ablation strategy with radioiodine among patients with low-risk thyroid cancer undergoing thyroidectomy. Read more.
Survivors of head and neck cancer appeared at increased risk for a second primary lung cancer. Read more.
An artificial intelligence platform predicted thyroid cancer with high accuracy based on analysis of routine ultrasound images. Read more.
Oropharyngeal cancer incidence and mortality have increased steadily among men in the United States during the past 2 decades. Read more.
A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer after treatment. Read more.
Use of radioactive iodine therapy in papillary thyroid cancer treatment has declined considerably since 2000 in favor of total thyroidectomy alone without radioactive iodine or lobectomy. Read more.
Among adults receiving treatment for low-risk thyroid cancer, negative emotions may play an important role in decision-making. Read more.

Published by:

Collapse

Source:

Healio Coverage

Related Content